Novo Nordisk Files False Advertising Lawsuit Against Eli Lilly Over Zepbound Ads Written By sheeba farhat22 July 2026 9:27 PM ISTLondon: Novo Nordisk sued rival Eli Lilly in a U.S. federal court ​on Tuesday, accusing the U.S. drugmaker of ​false advertising in claiming its...
Aspen's Generic Ozempic Gets Health Canada Approval, Launch Hinges on Dr Reddy's API Supply Written By sheeba farhat21 July 2026 8:44 PM ISTJohannesburg: South Africa's Aspen Pharmacare said on Monday that its Canadian subsidiary had received regulatory approval from Health Canada for...
Novo Nordisk to Launch Lower-Cost Ozempic Copy Extensior in South Africa Written By sheeba farhat18 July 2026 4:39 PM ISTJohannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering...
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging, reports research Written By Dr Kartikeya Kohli16 July 2026 12:45 PM ISTThe growing popularity of GLP-1 medications such as Ozempic, Wegovy, and Rybelsus has largely been driven by their ability to help people lose weight,...
Recalls by Dr Reddy's, Torrent Put Spotlight on Quality Standards in India's Semaglutide Market Written By Farhat Nasim10 July 2026 5:28 PM ISTNew Delhi: Three Indian pharmaceutical companies, Dr. Reddy's Laboratories, Torrent Pharmaceuticals and USV, have initiated voluntary recalls of...
USFDA Flags Misleading Claims on Compounded Semaglutide, Tirzepatide Products Written By sheeba farhat22 Jun 2026 5:24 PM ISTBengaluru: The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about...
India's GLP-1 Market Nears Rs 2,000 Crore as Semaglutide Boom Slows, Tirzepatide Regains Momentum Written By Susmita Roy21 Jun 2026 12:45 PM ISTNew Delhi: India's rapidly expanding GLP-1 agonist market is entering a new phase of maturity, with the explosive growth triggered by semaglutide...
Novo Nordisk Seeks Ban on Unregistered Semaglutide Products in South Africa Written By sheeba farhat11 Jun 2026 6:07 PM ISTPretoria: Danish drugmaker Novo Nordisk is heading to court in South Africa on Wednesday to try to halt the sale of unapproved copies of semaglutide,...
Ozempic, GPL-1s may help curb substance use disorders, UTEP study finds Written By Dr. Kamal Kant Kohli9 Jun 2026 8:45 PM ISTA new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated...
Experimental Pill Shows Promise for Type 2 Diabetes and Obesity: Study Written By Dr Kartikeya Kohli8 Jun 2026 8:15 PM ISTResearchers have found in a new study that a new experimental oral medication for type 2 diabetes and obesity may offer a novel treatment approach by...
Mounjaro Beats Ozempic-Class Drugs in Early Type 2 Diabetes Trial Written By sheeba farhat1 Jun 2026 10:52 PM ISTLondon: Recently diagnosed type 2 diabetes patients who did not respond well to a usual first-line treatment fared better after adding Eli Lilly's...
Brazil Approves First Semaglutide Pen as EMS Challenges Novo Nordisk's Ozempic Written By sheeba farhat27 May 2026 9:53 PM ISTSao Paulo: Brazil's health ​regulator Anvisa said on ​Tuesday it had approved EMS's ​Ozivy, the country's first semaglutide-based injector pen, as the...
